[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Indexing & Abstracting::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Creative commons

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

:: Search published articles ::
Showing 3 results for Cytotoxicity

Masoud Noroozianavval , Peghah Veisi, Mohammad Aghaeishahsavari , Hasan Argani, Nadere Rashtchizadeh, Amir Ghorbanihaghjo,
Volume 7, Issue 3 (9-2007)

  Background & Objectives : Panel-reactive antibody (PRA) is a routine test to evaluate for sensitized human leukocyte antigens (HLA) before kidney transplantation. The present study evaluates the correlation of renin-angiotensin system (RAS) polymorphisms with the level of PRA in renal transplant candidates.

  Methods: This study included 108 renal transplant candidates. The current patients sera were screened by standard complement-dependent microlymphocytotoxicity technique. RAS polymorphisms were determined by polymerase chain reaction. PRA<10, 10-29, 30-49, and ≥50 considered as negative, mild, moderate, and highly positive PRA, respectively.

  Results: Twelve (11.1%) patients had positive PRA, among them 10 (83.3%) had mild and 2 (16.7%) of them had moderate PRA levels we had no highly positive PRA. Ninety-six of cases (88.9%) were negative for PRA. There was no significant correlation between discrete RAS polymorphisms (alone or together) and the degree of panel antibody reactivity (P>0.05).

 Conclusion: We suggest that none of the RAS polymorphisms could predict the positivity degree of PRA level.

Hasan Hosainzadegan , Behrooz Ezzetpor , Fovad Abdollahpor , Masoumeh Motamedy , Marziyeh Rashidipor,
Volume 10, Issue 4 (12-2010)

 Background and Objectives: There are many problems in treatment of different kinds of tumors. Many studies were carried out for finding suitable antitumor materials in different countries. The aim of this study is to evaluate the antitumor effects of olive and green tea extracts on human breast tumor cell line (BT474).

 Methods: Water and ethanol extracts of green tea and olive were prepared. BT474 cells were treated with determinded concentration of extracts at different incubation times and cell lysis was measured using the lactate dehydrogenase enzyme assay. Experiments were repeated 3 times and the results expressed as means ± standard deviation. Statistical analysis were performed by t-test and p ≤ 0.05 considered as significant .

 Results: Increasing the concentration of green tea in 8 and 24 h exposures decreased cell lysis or killing percentage of treated cells. Olive extract in 1mg/dL concentration showed highest percent (85%) of cell lysis. Cell lysis effect of olive extract treatments was dose-dependent and increased in higher concentrations. There were no significant difference in killing effect of olive extract between 8 and 24 h incubation time (consequently 83% and 85%). But at the same incubation periods the difference between percent of cell lysis in the presence of green tea extracts (0.01 and 0.1 mg/dL) was significant. (p =0.000).

 Conclusions: Our results indicated that crude olive and green tea extractions have exerted lytic effects on BT 474 lines. Olive extract have higher cytotoxicity than green tea. Cytotoxicity of olive extract was dose-dependent .

Ameneh Basiri, Maryam Pashaiasl,
Volume 16, Issue 3 (10-2016)

Background & objectives: Among gynecologic malignancies, endometrial cancer is the fourth most frequent cause of cancer death all over the world. Paclitaxel is one of the chemotherapy regimens that is used against this cancer. Treatment of tumor with Paclitaxel induces apoptosis, but it is also associated with serious side effects. Thus, it is imperative to search for more effective and safer chemotherapeutic regimens. Silibinin is a milk thistle plant extract that its antioxidant effects against some cancers have been studied. The aim of this study was to examine the effect of Paclitaxel and Silibinin combination on endometrial cancer cell line (Hela).

Methods: Hela cell line was cultured in 25cm2 flask in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS). Then the numbers of live cells were calculated with trypan blue staining method and then the cells were seeded in to 96-well flat-bottomed culture plates and treated with Silibilin, Paclitaxel and Paclitaxel plus Silibilin together with the control without treatment. MTT assay was used to evaluate cytotoxicity of different treatments.

Results: After 48 hours of treatment, Paclitaxel and Silibilin combination inhibited cell growth significantly compared with the other groups (p<0.05).

Conclusions: It is indicated that combination of Paclitaxel and Silibilin can affect the growth arrest of Hela cancer cell line more  effective than other treatments and is needed to be examined in vitro.

Page 1 from 1     

مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.13 seconds with 31 queries by YEKTAWEB 4102